Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
Quick Stats
Jan 30, 202664.3
AI Score
BUY1.9
Volume Ratio
Feb 26, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
VRDN Stock Summary
Last updated Jan 30, 2026
VRDN is currently trading at $33, positioned above its 200-day moving average of $21.37, indicating a long-term uptrend. The stock has a 52-week range of $9.9 to $34.29.
Technical Analysis: The 50-day moving average stands at $31.84, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 56.198, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.33, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates VRDN at 64.3/100 with a BUY recommendation.
VRDN (Viridian Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 56.198 |
| CMF (20) | 0.33 |
| ROC (10) | -0.091 |
| ADX (14) | 22.195 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.616 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -41.214 |
| MFI (14) | 54.585 |
VRDN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
VRDN Price vs Max Options Open Interest
VRDN Max Change In Options Open Interest
VRDN Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRDN Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRDN Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRDN Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Viridian Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
VRDN Moving Averages Analysis
Viridian Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Viridian Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
VRDN (Viridian Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 33.01 |
| 20 | 32.29 |
| 30 | 32.12 |
| 50 | 31.84 |
| 100 | 27.14 |
| 200 | 21.37 |
VRDN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.1 billion |
| Earnings/Share ($) | -2.98 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.5413 |
| EPS Estimate Next Year ($) | -3.6072 |
| WallStreet Target Price ($) | 41.8824 |
| Most Recent Quarter |